Form 483

Innovacyn Inc. Form 483, 2013-05-16

FDA issued a Form 483 to Innovacyn Inc. on 2013-05-16 with 6 public-safe observations.

483· Form 483 issuedAnimal Drugs & Feeds6 observations

Innovacyn Inc. · Rialto, United States · Issued May 16, 2013

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

16 May 2013
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Carla J Lundi

16 May 2013
21 CFR 211.160(b)(3)

Acceptance of drug products

Cited by Carla J Lundi

16 May 2013
21 CFR 211.165(b)

Microbiological testing

Cited by Carla J Lundi

16 May 2013
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Carla J Lundi

16 May 2013
21 CFR 820.75(a)

Lack of or inadequate process validation

Cited by Carla J Lundi

Inspected site

IIInnovacyn Inc.Rialto, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.165(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 820.75(a)Cited across public-safe Form 483 observations1x
21 CFR 820.80(d)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere